Found: 244
Select item for more details and to access through your institution.
Comment on: Comparison of carbapenem MIC for NDM-producing Enterobacterales by different AST methods: considerations for media composition.
- Published in:
- 2024
- By:
- Publication type:
- Letter to the Editor
Imipenem/relebactam pharmacokinetics in critically ill patients supported on extracorporeal membrane oxygenation.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 5, p. 1118, doi. 10.1093/jac/dkae079
- By:
- Publication type:
- Article
Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 5, p. 1176, doi. 10.1093/jac/dkae089
- By:
- Publication type:
- Article
Deciphering the Efficacy of β-Lactams in the Face of Metallo-β-Lactamase-Derived Resistance in Enterobacterales: Supraphysiologic Zinc in the Broth Is the Culprit.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 5, p. 1, doi. 10.1093/ofid/ofae228
- By:
- Publication type:
- Article
Assessing the in vivo impact of novel β-lactamase inhibitors on the efficacy of their partner β-lactams against serine carbapenemase-producing Pseudomonas aeruginosa using human-simulated exposures.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 546, doi. 10.1093/jac/dkad412
- By:
- Publication type:
- Article
In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 2, p. 412, doi. 10.1093/jac/dkad396
- By:
- Publication type:
- Article
Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
- Published in:
- American Journal of Health-System Pharmacy, 2024, v. 81, n. 1, p. e21, doi. 10.1093/ajhp/zxad232
- By:
- Publication type:
- Article
Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 2795, doi. 10.1093/jac/dkad225
- By:
- Publication type:
- Article
In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 2801, doi. 10.1093/jac/dkad244
- By:
- Publication type:
- Article
Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and clinicians.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2242, doi. 10.1093/jac/dkad229
- By:
- Publication type:
- Article
Imipenem/funobactam (formerly XNW4107) in vivo pharmacodynamics against serine carbapenemase-producing Gram-negative bacteria: a novel modelling approach for time-dependent killing.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2343, doi. 10.1093/jac/dkad242
- By:
- Publication type:
- Article
Assessing the in vivo efficacy of rational antibiotics and combinations against difficult-to-treat Pseudomonas aeruginosa producing GES β-lactamases.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 8, p. 1843, doi. 10.1093/jac/dkad098
- By:
- Publication type:
- Article
A Retrospective Case Series of Concomitant Carbapenem and Valproic Acid Use: Are Best Practice Advisories Working?
- Published in:
- Journal of Pharmacy Practice, 2023, v. 36, n. 3, p. 537, doi. 10.1177/08971900211063301
- By:
- Publication type:
- Article
Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance
- Published in:
- JAC-Antimicrobial Resistance, 2023, v. 5, n. 2, p. 1, doi. 10.1093/jacamr/dlad011
- By:
- Publication type:
- Article
In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 4, p. 983, doi. 10.1093/jac/dkad032
- By:
- Publication type:
- Article
Phenotypes, genotypes and breakpoints: an assessment of β-lactam/β-lactamase inhibitor combinations against OXA-48.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 3, p. 636, doi. 10.1093/jac/dkac425
- By:
- Publication type:
- Article
In vivo pharmacokinetic/pharmacodynamic evaluation of cefepime/taniborbactam combination against cefepime-non-susceptible Enterobacterales and Pseudomonas aeruginosa in a murine pneumonia model.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 3, p. 692, doi. 10.1093/jac/dkac446
- By:
- Publication type:
- Article
Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 3, p. 703, doi. 10.1093/jac/dkac447
- By:
- Publication type:
- Article
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia.
- Published in:
- Critical Care, 2023, p. 1, doi. 10.1186/s13054-023-04331-x
- By:
- Publication type:
- Article
In vivo pharmacokinetics and pharmacodynamics of ceftibuten/ledaborbactam, a novel oral β-lactam/β-lactamase inhibitor combination.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 1, p. 93, doi. 10.1093/jac/dkac359
- By:
- Publication type:
- Article
Relative bioavailability of crushed tebipenem administered through a nasogastric tube with and without enteral feeding.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 1, p. 205, doi. 10.1093/jac/dkac375
- By:
- Publication type:
- Article
Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 1, p. 252, doi. 10.1093/jac/dkac385
- By:
- Publication type:
- Article
Pharmacokinetics and soft-tissue distribution of tebipenem pivoxil hydrobromide using microdialysis: a study in healthy subjects and patients with diabetic foot infections.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 1, p. 296, doi. 10.1093/jac/dkac399
- By:
- Publication type:
- Article
Carbapenem-resistant Pseudomonas aeruginosa: an assessment of frequency of isolation from ICU versus non-ICU, phenotypic and genotypic profiles in a multinational population of hospitalized patients.
- Published in:
- Antimicrobial Resistance & Infection Control, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s13756-022-01187-8
- By:
- Publication type:
- Article
Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearance.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 11, p. 2992, doi. 10.1093/jac/dkac261
- By:
- Publication type:
- Article
Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 11, p. 3187, doi. 10.1093/jac/dkac304
- By:
- Publication type:
- Article
Phenotypes, genotypes and breakpoints: an assessment of β-lactam/ β-lactamase inhibitor combinations against OXA-48.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Plasma and cerebrospinal fluid concentrations of cefiderocol during successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
In vivo translational assessment of the GES genotype on the killing profile of ceftazidime, ceftazidime/avibactam and meropenem against Pseudomonas aeruginosa.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmacokinetic Analysis and In Vitro Synergy Evaluation of Cefiderocol, Sulbactam, and Tigecycline in an Extensively Drug-Resistant Acinetobacter baumannii Pneumonia Patient Receiving Continuous Venovenous Hemodiafiltration.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Impact of a Pharmacist-Managed Procalcitonin Program on COVID-19 Respiratory Tract Infection Outcomes and Health Care Resource Utilization.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 9, p. 1, doi. 10.1093/ofid/ofac468
- By:
- Publication type:
- Article
Impact of Order-Set Modifications and Provider Education Following Guideline Updates on Broad-Spectrum Antibiotic Use in Patients Admitted With Community Acquired Pneumonia.
- Published in:
- Hospital Pharmacy, 2022, v. 57, n. 4, p. 496, doi. 10.1177/00185787211055797
- By:
- Publication type:
- Article
In vivo efficacy of WCK 6777 (ertapenem/zidebactam) against carbapenemase-producing Klebsiella pneumoniae in the neutropenic murine pneumonia model.
- Published in:
- 2022
- By:
- Publication type:
- journal article
In vivo exposure-response relationship of meropenem against metallo-β-lactamase-harbouring Pseudomonas aeruginosa: an assessment using MICs from conventional and zinc-limited broth.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 7, p. 1938, doi. 10.1093/jac/dkac141
- By:
- Publication type:
- Article
Assessment of sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Acinetobacter baumannii using in vitro chemostat and in vivo murine infection models.
- Published in:
- JAC-Antimicrobial Resistance, 2022, v. 4, n. 3, p. 1, doi. 10.1093/jacamr/dlac047
- By:
- Publication type:
- Article
Omadacycline pharmacokinetics and soft-tissue penetration in diabetic patients with wound infections and healthy volunteers using in vivo microdialysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Intrapulmonary Pharmacokinetic Modeling and Simulation of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients With Pneumonia and Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2022, v. 62, n. 5, p. 670, doi. 10.1002/jcph.1986
- By:
- Publication type:
- Article
Minocycline pharmacodynamics against Stenotrophomonas maltophilia in the neutropenic murine infection model: implications for susceptibility breakpoints.
- Published in:
- 2022
- By:
- Publication type:
- journal article
In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy?
- Published in:
- Brazilian Journal of Infectious Diseases, 2022, v. 26, n. 2, p. 1, doi. 10.1016/j.bjid.2022.102355
- By:
- Publication type:
- Article
Murine Model for Measuring Effects of Humanized-Dosing of Antibiotics on the Gut Microbiome.
- Published in:
- Frontiers in Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fmicb.2022.813849
- By:
- Publication type:
- Article
Clinical exposure-response relationship of cefepime/taniborbactam against Gram-negative organisms in the murine complicated urinary tract infection model.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multicenter, Prospective Validation of a Phenotypic Algorithm to Guide Carbapenemase Testing in Carbapenem-Resistant Pseudomonas aeruginosa Using the ERACE-PA Global Surveillance Program.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 2, p. 1, doi. 10.1093/ofid/ofab617
- By:
- Publication type:
- Article
Evaluation of high-concentration EDTA-modified carbapenemase inactivation method (eCIM) for SPM-producing Pseudomonas aeruginosa.
- Published in:
- Archives of Microbiology, 2022, v. 204, n. 1, p. 1, doi. 10.1007/s00203-021-02681-0
- By:
- Publication type:
- Article
Levofloxacin pharmacodynamics against Stenotrophomonas maltophilia in a neutropenic murine thigh infection model: implications for susceptibility breakpoint revision.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 12, p. 2533, doi. 10.1007/s10096-021-04308-0
- By:
- Publication type:
- Article
Comment on: An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa.
- Published in:
- 2021
- By:
- Publication type:
- letter
Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Erratum to: Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2021, v. 76, n. 11, p. 3069, doi. 10.1093/jac/dkab343
- By:
- Publication type:
- Article
Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo murine infection models.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy assessment of lysin CF-296 in addition to daptomycin or vancomycin against Staphylococcus aureus in the murine thigh infection model.
- Published in:
- 2021
- By:
- Publication type:
- journal article